Understanding the Opioid Epidemic: When Innovation Fails, or Rather Works Too Well
The opioid crisis provides a deadly example of why innovation often is simply a new-fangled form of predation.
Read more...Category Archives: Ridiculously obvious scams
Purdue Bankruptcy Plan Moves Closer to Approval: Sacklers Would Make Out Well and Preserve Much of the Family Fortune, Despite the Opioids Crisis
Last week fifteen states dropped opposition to Purdue Pharma’s bankruptcy exit plan, making it likely the plan will be approved when it comes before a federal bankruptcy judge in August.
Read more...Drugmakers’ Spending on Stock, Dividends and Executive Pay Exceeds Research, Democrats Say
The largest drug companies are far more interested in enriching themselves and investors than in developing new drugs, according to a House committee report released Thursday
Read more...Book Review: The History of Animal-Based Medicine in China
Even critics of animal-based potions in China don’t understand its origins….which means they may be easier to contain than is now assumed.
Read more...Moving the Covid Vaccine Goalposts
The Covid propagation and vaccine news is not pointing to happy outcomes
Read more...Wall Street Journal Fingers Columbia as Leader in Grad Students Whose Student Debt Leaves Them ‘Financially Hobbled for Life’
Columbia stands out in what a bad deal its graduate arts programs are. And President Bollinger is either clueless or indifferent.
Read more...The Future of Alzheimer’s Pharmaceutical Aducanumab – as a Medicine and as a Financial Product – What Happens Now?
The more you look at aducanumab, both the dubious FDA approval and the thin odds that it will perform medically, the less there is to like.
Read more...War on Science Persists Within Biden EPA as Staffers Allege Chemical Reports Altered
Whistleblowers charge that Trump-style doctoring of scientific reports is continuing under Biden.
Read more...How Intel Financialized and Lost Leadership in Semiconductor Fabrication
Intel is the poster child of how stock buybacks come at the cost of technological innovation.
Read more...Aducanumab Approval, Part 2: Dirty Drug Dealings
Yves here. We’re doing a bit of catchup by featuring some significant stories that were still crowded out a bit due to the competing news plus the Fourth of July tuneout. One is on the super dodgy approval of the big ticket, very dubious effectiveness Alzheimer’s drug Aducanumab. And “big ticket” is no understatement; the […]
Read more...Democrats Prepare to Privatize Medicare, Using Medicare Advantage as Their Opening Wedge (and New York Unions?)
The Democrat plan to privatize Medicare by expanding the private, for-profit Medicare Advantage program
Read more...Biden Administration Issues Interim Rule Barring Surprise Billing
The health care grift knows as surprise billing is about to be largely stamped out.
Read more...Health Insurance Tricks and Traps: Using Cheap at Home Colon Cancer Test Exposes Insureds to Big Colonoscopy Bill
Why colonoscopy testing looks an awful lot like neoliberal rent extraction, as least as practiced in the US.
Read more...Ralph Nader: Leaves Must be Canceled. All Hands on the Congressional Deck.
Ralph Nader pens an open letter to House Speaker Nancy Pelosi and Senate Majority Leader Chuck Schumer.
Read more...Will Tether Bring All The Cryptocurrencies Way Down?
The more you look at the cryptocurrency Tether, the less there is to like.
Read more...